Neoadjuvant Therapy

Subscribe to Selected New Research on Neoadjuvant Therapy

1365 relevant articles (101 outcomes, 241 trials/studies) found for this Therapy

Description: Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Also Known As:

Neoadjuvant Therapies; Neoadjuvant Treatments; Therapies, Neoadjuvant; Therapy, Neoadjuvant; Treatment, Neoadjuvant; Treatments, Neoadjuvant; Neoadjuvant Treatment

Relationship Network

Therapy Context: Research Results

Therapeutics: 5232

Combined Modality Therapy: 1511

Neoadjuvant Therapy: 1365

Experts

1.	Hortobagyi, Gabriel N: 5 articles (03/2008 - 06/2005)
2.	Thomas, M: 5 articles (09/2005 - 04/2000)
3.	Junker, K: 5 articles (05/2005 - 04/2000)
4.	Siewert, J R: 5 articles (11/2004 - 12/2000)
5.	Imdahl, Andreas: 4 articles (01/2008 - 01/2004)
6.	Scambia, Giovanni: 4 articles (04/2007 - 03/2002)
7.	Smith, Ian E: 4 articles (10/2006 - 09/2003)
8.	Müller, K-M: 4 articles (05/2005 - 01/2003)
9.	van Lanschot, J Jan B: 3 articles (12/2008 - 09/2005)
10.	Ott, Katja: 3 articles (09/2008 - 09/2003)

Related Diseases

1.	Neoplasms (Cancer) 11/01/2000 - "Moreover, the clips helped the surgeon to define the primary tumor region following marked regression after neoadjuvant therapy in 3 patients" 05/01/1998 - "The potential for radical craniofacial surgery for complete en bloc resection, the availability of advanced neuroimaging modalities, and the incorporation of neoadjuvant therapy into treatment strategies for tumor remission have all contributed to this accomplishment" 05/01/1998 - "Finally, Doppler studies have provided good results in the follow-up of breast cancers after neoadjuvant therapy" 12/01/2000 - "CONCLUSIONS: Patients with N2-positive NSCLC whose nodal disease is eradicated after neoadjuvant therapy and surgery enjoy significantly improved cancer-free survival" 01/01/1999 - "The percentage of cancers with negative margins was statistically significantly greater in patients treated with neoadjuvant therapy than those treated with immediate surgery alone (69% vs. 42%, respectively)" Order ALL the reference details at left...
2.	Breast Neoplasms (Breast Cancer) 03/01/1987 - "There are several theoretical reasons why neoadjuvant treatment might be of particular benefit, and even if it ultimately transpires that breast cancer is not an ideal model disease for this approach, it does not preclude this particular technique for being effective in other types of malignancy." 10/01/2007 - "These include neoadjuvant treatment, immediate and delayed adjuvant treatment, salvage treatment and first-line treatment of advanced breast cancer" 05/01/2006 - "Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: a pilot study." 08/15/2008 - "These scoring systems facilitated separation of the study population into more refined subgroups by outcome than the current AJCC staging system for breast cancer, and provide a novel means for evaluating prognosis after neoadjuvant therapy." 11/01/2007 - "METHODS: Stage I, II, and III breast cancer patients were treated with neoadjuvant therapy on trial" Order ALL the reference details at left...
3.	Rectal Neoplasms (Rectal Cancer) 08/01/2006 - "BACKGROUND: Neoadjuvant therapies have significantly improved local control and survival of patients with rectal cancer" 05/01/2000 - "BACKGROUND: The role of surgery in the therapeutic balance of locally advanced rectal neoplasms needs to be redefined in the light of recent reports on the efficacy of radio- and chemotherapy in neoadjuvant treatment" 09/01/2003 - "This is the first study suggesting that detection of disseminated rectal cancer cells may be useful for assessing the efficacy of neoadjuvant therapy." 08/01/2007 - "PURPOSE: Efficacy of F-18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT) for determining neoadjuvant therapy response in rectal cancer is not well established" 08/01/2007 - "Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy." Order ALL the reference details at left...
4.	Neoplasm Metastasis (Metastasis) 01/03/2008 - "Neoadjuvant treatment and multimodal approaches may increase the proportion of patients with resectable liver metastases, and better preoperative imaging may help to more carefully select patients who can benefit from this treatment." 03/01/2001 - "Survival was not affected by the homolateral location of the metastasis, the histology of the NSCLC, TNM stage, any adjuvant and neoadjuvant treatment, or, in the metachronous group, a disease-free interval exceeding 6 months" 05/01/1997 - "Although this model cannot address the issue of effect of neoadjuvant therapy on subclinical metastases, extrapolation of these results to the clinical disease suggests that neoadjuvant therapy may help to decrease not only the positive margin rates but also the subsequent risk of local recurrence following radical prostatectomy." 01/01/2003 - "After a period of focusing on the identification technique, biopsy and histological examination of the SN (October 97-January 98) always followed by a complete dissection of the three axillary node levels (ALND), we started a study to evaluate the reliability of a limited dissection of the 1st level of the axilla (FLND) in women with T < 3 cm, N0-1a, M0, that did not undergo any neoadjuvant treatment and in which the SN resulted free from metastases" 11/01/2001 - "Novel approaches with immunotherapy and trials of neoadjuvant therapy in association with resection of CRC hepatic metastases have also been reported" Order ALL the reference details at left...
5.	Esophageal Neoplasms (Esophageal Cancer) 01/01/2000 - "Studies on neoadjuvant therapy of esophageal cancer showed that not either preoperative chemotherapy or radiotherapy lead to a significant improvement of prognosis" 07/01/1998 - "A careful risk analysis is crucial for a reduced postoperative mortality and anastomotic failure rate and neoadjuvant therapy facilitates down staging of tumours, thus aiding in high resectability rates with significantly improved long term survival in patients with esophageal cancer." 10/01/2008 - "This article discusses the clinical efficacy of PET in staging and surveillance of neoadjuvant therapy in esophageal cancer, comparing its accuracy with conventional imaging modalities." 12/01/2004 - "This article aims to evaluate the feasibility and efficacy of laparoscopic esophagectomy for the palliative treatment of advanced esophageal cancer (T3-T4 Nx-N1) after neoadjuvant therapy" 03/01/2000 - "CONCLUSIONS: An immunohistochemical analysis of p53 and the Ki-67 labeling percentage using biopsied specimens was thus found to effectively predict the efficacy of neoadjuvant therapies in patients with esophageal cancer." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	capecitabine (Xeloda)
3.	oxaliplatin (Eloxatin)
4.	Cisplatin (Platino)
5.	Paclitaxel (Taxol)
6.	letrozole (Femara)
7.	Epirubicin (Ellence)
8.	Tamoxifen
9.	docetaxel (Taxotere)
10.	Doxorubicin (Adriamycin)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Prostatectomy (Retropubic Prostatectomy)
3.	Segmental Mastectomy (Lumpectomy)
4.	Esophagectomy
5.	Combined Modality Therapy

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18531 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>